Work

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.3684.3684

Authors: Dan T. Vogl, Edward A. Stadtmauer, James E. Bradner, Lisa Davis, Martin Carroll, Charles W. Nichols, Doris Shank, Mary Carberry, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Craig B. Thompson, Ravi K. Amaravadi

Institutions: Abramson Cancer Center, University of Pennsylvania, Dana-Farber Cancer Institute, University of the Sciences

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2570310697

FWCI: 0.191

Cites:

Cited by: 2

Related to: 10